Skip to main content
Gour Medical logo

Gour Medical — Investor Relations & Filings

Ticker · MLGML ISIN · FR0013371507 LEI · 969500J01B2O4RQ0K260 PA Manufacturing
Filings indexed 34 across all filing types
Latest filing 2019-05-28 Report Publication Anno…
Country FR France
Listing PA MLGML

About Gour Medical

http://gour-medical.com

Based on the provided information, there is no specific data available regarding the core business activities, products, or services of Gour Medical. The supplied documentation pertains to a different entity operating in the online gaming sector and general information about a national healthcare system, neither of which contains verifiable details about the company.

Recent filings

Filing Released Lang Actions
LANCEMENT DE WEEDLEY : PREMIERE GAMME EUROPEENNE DE SOLUTIONS PREMIUM À BASE DE CANNABIDIOL FULL SPECTRUM POUR L'ANIMAL DE COMPAGNIE
Report Publication Announcement Classification · 99% confidence The document is titled 'COMMUNIQUE DE PRESSE' (Press Release) and announces the launch of a new product line ('Weedley'). It contains quotes from the CEO and management, market analysis related to the product (CBD for pets), and concludes with a section titled 'Prochaine publication: Mardi 9 juillet 2019 : Activité du 1er semestre 2019 (après-bourse)'. This structure—a formal announcement of a business event (product launch) combined with forward-looking statements and a notice about a future financial report—is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it is a press release announcing a significant business development (product launch) rather than a full financial report (like 10-K or IR) or a transcript (CT), the most fitting category is Earnings Release (ER), as these often accompany or precede formal earnings reports, or Regulatory Filings (RNS) as a general announcement. Given the focus on a major business event and market context, ER is plausible, but since it is not explicitly stating quarterly/periodical financial results (only announcing the *next* financial report date), and it is a general press release about a product launch, the most appropriate general category for non-standard, important announcements is Regulatory Filings (RNS). However, the content strongly resembles an Earnings Release in tone and structure (CEO commentary, market context, future report date). Since the document is a press release announcing a major operational event (product launch) and includes market context, it functions similarly to an ER, but RNS is the safest fallback for non-standard press releases. Let's re-evaluate based on definitions. It is not a 10-K, AR, CT, or IR. It is not a DIV, NAV, or DIRS. It is a press release. If it were purely about results, it would be ER. Since it's a product launch announcement, it fits best under RNS (Regulatory Filings / General Announcement) or potentially ER if the company uses product launches as the primary announcement vehicle. Given the explicit mention of the next financial report date, it leans towards being an announcement related to financial reporting cycles, making ER a strong candidate, but RNS covers general press releases well. I will classify it as RNS as it is a general press release announcing a business development, which is the fallback for non-specific filings.
2019-05-28 French
NOMINATION DE M. GILLES AVENARD AU SEIN DU CONSEIL D'ADMINISTRATION
Board/Management Information Classification · 99% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces the appointment of Gilles Avenard to the Board of Directors, effective April 29, 2019. This content directly relates to changes in the company's board of directors or senior management. This aligns perfectly with the definition for Board/Management Information (MANG). The document is short and functions as an announcement, not a comprehensive report like a 10-K or IR.
2019-04-30 French
GOUR MEDICAL ANNONCE LE SUCCES DE SON AUGMENTATION DE CAPITAL
Share Issue/Capital Change Classification · 99% confidence The document is titled 'COMMUNIQUE DE PRESSE' (Press Release) and its main subject is 'GOUR MEDICAL ANNONCE LE SUCCES DE SON AUGMENTATION DE CAPITAL PAR PLACEMENT PRIVE' (GOUR MEDICAL ANNOUNCES THE SUCCESS OF ITS CAPITAL INCREASE VIA PRIVATE PLACEMENT). The text details the issuance of new shares, the price, the total amount raised (approximately 115,000 euros), and the resulting change in share capital structure. This content directly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it involves a capital change (SHA), the primary focus is the successful completion of the financing event itself, making CAP the most precise classification.
2019-04-17 French
CHANGEMENT DE CODE ISIN À COMPTER DU 23 AVRIL 2019
Regulatory Filings Classification · 91% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a specific corporate action: the change of the ISIN code for trading shares, effective April 23, 2019, due to a headquarters transfer. It details the operational calendar for this change. This type of announcement, which is a formal notification of a change affecting trading or capital structure but is not a full financial report (like 10-K or IR), fits best under categories related to corporate actions or general regulatory announcements. Since it involves a change in the security identifier (ISIN) and trading mechanism, it is a significant corporate event announcement. While it touches upon capital structure indirectly, it is primarily a notification about the security itself. Given the options, it is a specific corporate announcement. It is too specific for the general 'RNS' fallback. It is not a dividend (DIV), share issue (SHA), or transaction in own shares (POS). It is a notification about the security's identification. The closest fit for a specific, non-financial-result-focused corporate update that doesn't fit elsewhere is often a general regulatory filing or a capital/financing update if the change is deemed structural. However, since it is a formal press release announcing a change in trading details (ISIN), it is best classified as a general regulatory announcement or a specific corporate action notice. Given the options, 'RNS' (Regulatory Filings - general regulatory announcements and fallback) is appropriate for specific, non-standard corporate news releases that don't fit the other defined categories like DIV, SHA, or CAP. Alternatively, since it relates to the security's listing details, it could be seen as a minor capital structure event, but 'RNS' is the safest general classification for a press release detailing an administrative change like an ISIN swap.
2019-04-16 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.